| Value | ₹881.9 Cr |
|---|---|
| Execution period | 15 years from 18.11.2024 |
BSE filing, NSE: MEGASTAR. Summary written from the filing by ALFA Finder's alert engine.
Megastar Foods Ltd: key numbers
- Share price
- ₹285.48
- Market cap
- ₹322.4 Cr
- Revenue (annual)
- ₹532.6 Cr
- Net profit (annual)
- ₹9.30 Cr
- P/E (TTM)
- 34.7×Sector 27.1×
- Promoter holding
- 61.47%+0.00% QoQ
- FII holding
- 6.19%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Megastar Foods Ltd
All →Megastar Foods Board Meeting Date
Megastar Foods scheduled a board meeting on 2 Nov 2026 to consider Q2 FY27 financial results. Trading window remains closed till 4 Nov 2026.
Megastar Foods Other Announcement
Megastar Foods Limited submitted a certificate under SEBI Regulation 74(5) regarding dematerialization of securities for the quarter ended September 30, 2026.
Megastar Foods Annual General Meeting
Megastar Foods Limited held its 15th Annual General Meeting on September 23, 2026. Business included adopting financial statements and re-appointing a director.
Megastar Foods Legal & Regulatory
Megastar Foods received a GST order-in-appeal reducing its tax demand to Rs. 1.74 Crore. The company intends to appeal this decision before the GST Appellate Tribunal.
- Value
- ₹1.74 Cr
Megastar Foods Other Announcement
Megastar Foods informed the exchange it communicated with shareholders lacking registered email addresses, providing weblinks to the 15th AGM Notice and FY 2025-26 Annual Report.
Megastar Foods Annual General Meeting
Megastar Foods Limited has scheduled its 15th Annual General Meeting for September 23, 2026. The filing provides the notice and Annual Report for FY 2025-26.
Other regulatory approval announcements
All →Grasim Industries Regulatory Approval
CCI approved subsidiary ABReN's acquisition of 100% of Solenergi Power from Shell Overseas. The approval clears a regulatory condition for the deal announced on 13 July 2026.
Vedavaag Systems Regulatory Approval
Vedavaag's WOS received IRDAI Certificate of Registration to act as Direct Life & General Insurance Broker. The group enters regulated insurance broking activity.
Hikal Regulatory Approval
Hikal's Bengaluru API facility received a Swissmedic GMP Certificate of Compliance. The certification supports wider access to European and other regulated markets.
Sun Pharmaceutical Industries Regulatory Approval
Sun Pharma gained US FDA approval for ILUMYA in adults with active psoriatic arthritis. The approval extends the drug's psoriasis use, with no financial value stated.
RNFI Services Regulatory Approval
RNFI received RBI no-objection to acquire control of Smart Payment Solutions Private Limited. Remaining tranches may proceed, but no transaction value is disclosed.
Shalby Regulatory Approval
Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.